A Phase Ib/II trial of SB 11285 in liver cancer
Phase of Trial: Phase I/II
Latest Information Update: 01 Nov 2018
At a glance
- Drugs SB 11285 (Primary) ; SB 11285 (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2018 According to a Spring Bank Pharmaceuticals media release, the company plans to initiate this trial in 2019.
- 07 Nov 2017 New trial record
- 31 Oct 2017 According to a Spring Bank Pharmaceuticals media release, the company is planning to submit an IND, and/or a CTA in mid-2018 to start this trial in the second half of 2018.